Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 5
2007 4
2008 11
2009 15
2010 8
2011 9
2012 12
2013 19
2014 16
2015 33
2016 34
2017 39
2018 38
2019 52
2020 64
2021 78
2022 105
2023 105
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

602 results

Results by year

Filters applied: . Clear all
Page 1
Nox4 as a novel therapeutic target for diabetic vascular complications.
Wang D, Li J, Luo G, Zhou J, Wang N, Wang S, Zhao R, Cao X, Ma Y, Liu G, Hao L. Wang D, et al. Among authors: cao x. Redox Biol. 2023 Aug;64:102781. doi: 10.1016/j.redox.2023.102781. Epub 2023 Jun 9. Redox Biol. 2023. PMID: 37321060 Free PMC article. Review.
Transcriptomics, proteomics, metabolomics and network pharmacology reveal molecular mechanisms of multi-targets effects of Shenxianshengmai improving human iPSC-CMs beating.
Hu Y, Chen L, Zhao S, Feng R, Cao X, Chen G, Zhao T, Zhang C, Fang Z, Guo Z, Yu X, Zhang Z, Abdurahman M, Hong H, He Y, Li H. Hu Y, et al. Among authors: cao x. Clin Transl Med. 2023 Jun;13(6):e1302. doi: 10.1002/ctm2.1302. Clin Transl Med. 2023. PMID: 37282796 Free PMC article. No abstract available.
Single-cell technologies: From research to application.
Wen L, Li G, Huang T, Geng W, Pei H, Yang J, Zhu M, Zhang P, Hou R, Tian G, Su W, Chen J, Zhang D, Zhu P, Zhang W, Zhang X, Zhang N, Zhao Y, Cao X, Peng G, Ren X, Jiang N, Tian C, Chen ZJ. Wen L, et al. Among authors: cao x. Innovation (Camb). 2022 Oct 18;3(6):100342. doi: 10.1016/j.xinn.2022.100342. eCollection 2022 Nov 8. Innovation (Camb). 2022. PMID: 36353677 Free PMC article. Review.
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults.
Aliprantis AO, Shaw CA, Griffin P, Farinola N, Railkar RA, Cao X, Liu W, Sachs JR, Swenson CJ, Lee H, Cox KS, Spellman DS, Winstead CJ, Smolenov I, Lai E, Zaks T, Espeseth AS, Panther L. Aliprantis AO, et al. Among authors: cao x. Hum Vaccin Immunother. 2021 May 4;17(5):1248-1261. doi: 10.1080/21645515.2020.1829899. Epub 2020 Oct 29. Hum Vaccin Immunother. 2021. PMID: 33121346 Free PMC article. Clinical Trial.
Carbohydrate-based drugs launched during 2000-2021.
Cao X, Du X, Jiao H, An Q, Chen R, Fang P, Wang J, Yu B. Cao X, et al. Acta Pharm Sin B. 2022 Oct;12(10):3783-3821. doi: 10.1016/j.apsb.2022.05.020. Epub 2022 May 23. Acta Pharm Sin B. 2022. PMID: 36213536 Free PMC article. Review.
Purinoceptor: a novel target for hypertension.
Li X, Zhu LJ, Lv J, Cao X. Li X, et al. Among authors: cao x. Purinergic Signal. 2023 Mar;19(1):185-197. doi: 10.1007/s11302-022-09852-8. Epub 2022 Feb 18. Purinergic Signal. 2023. PMID: 35181831 Free PMC article. Review.
P2X7 Receptor-Mediated Inflammation in Cardiovascular Disease.
Zhou J, Zhou Z, Liu X, Yin HY, Tang Y, Cao X. Zhou J, et al. Among authors: cao x. Front Pharmacol. 2021 Apr 29;12:654425. doi: 10.3389/fphar.2021.654425. eCollection 2021. Front Pharmacol. 2021. PMID: 33995071 Free PMC article. Review.
602 results